Skip to content
Research/Peptide Blends Stacks/IGF-1 LR3 + MOTS-c

IGF-1 LR3 + MOTS-c

Metabolic + Anabolic stack. Combines IGF-1 anabolic effects with MOTS-c metabolic/mitochondrial support for body composition optimization.

Intelligence Profile

Science

Mechanism of Action

Limited evidence available for this combination therapy.

Based on general knowledge of the individual components, this combination would theoretically work through two distinct pathways:

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1):
IGF-1 LR3 is a synthetic analog of IGF-1 with modifications that extend its half-life and reduce binding to IGF binding proteins. IGF-1 typically works by binding to IGF-1 receptors, activating downstream signaling pathways including PI3K/Akt and MAPK cascades that promote protein synthesis, cell growth, and tissue repair.

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c):
MOTS-c is a mitochondrial-derived peptide that appears to regulate cellular metabolism. It is thought to activate AMP-activated protein kinase (AMPK) pathways, potentially improving glucose uptake, enhancing mitochondrial function, and promoting metabolic flexibility.

Important Limitations:
No published research was found specifically examining this IGF-1 LR3 + MOTS-c combination. The proposed mechanisms are based on theoretical understanding of each component individually, not empirical evidence of their combined effects. The safety profile, optimal dosing, potential interactions, and clinical efficacy of this combination remain unknown.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with a qualified healthcare provider before considering any experimental therapies.